The use of propranolol in the treatment of periocular infantile haemangiomas: A review

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1199-1202

  Claerhout, Ilse ^a   Buijsrogge, M ^a   Delbeke, P ^a   Walraedt, S ^a   De Schepper, S ^a   De Moerloose, B ^a   De Groote, K ^a   Decock, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FIBROBLAST GROWTH FACTOR; GLUCOSE; PROPRANOLOL; STEROID; VASCULOTROPIN;

ANISOMETROPIA; APOPTOSIS; ASTIGMATISM; BRADYCARDIA; BRONCHOSPASM; CAPILLARY HEMANGIOMA; CELL MATURATION; CLINICAL PROTOCOL; CONGENITAL HEART MALFORMATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ELECTROCARDIOGRAM; ENDOTHELIUM CELL; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; LOWER RESPIRATORY TRACT INFECTION; PATIENT MONITORING; PERIOCULAR INFANTILE HEMANGIOMA; PRIORITY JOURNAL; PULSE RATE; REVIEW; TREATMENT DURATION; TUMOR GROWTH; TUMOR VOLUME; VASOCONSTRICTION;

ADRENERGIC BETA-ANTAGONISTS; DISEASE PROGRESSION; EYE NEOPLASMS; HEMANGIOMA, CAPILLARY; HUMANS; INFANT; ORBITAL NEOPLASMS; PROPRANOLOL; TREATMENT OUTCOME;

EID: 80052135845     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.192245     Document Type: Review

References (30)

1. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150:291-4.
2. Haik BG, Jakobiec FA, Ellsworth RM, et al. Capillary hemangioma of the lids and orbit: an analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology 1979;86:760-92.
3. Haik BG, Karcioglu ZA, Gordon RA, et al. Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmol 1994;38:399-426.
4. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983;18:894-900.
5. Robb RM. Refractive errors associated with hemangiomas of the eyelids and orbit in infancy. Am J Ophthalmol 1977;83:52-8.
6. Stigmar G, Crawford JS, Ward CM, et al. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit. Am J Ophthalmol 1978;85:806-13.
7. Bogan S, Simon JW, Krohel GB, et al. Astigmatism associated with adnexal masses in infancy. Arch Ophthalmol 1987;105:1368-70.
8. Weiss AH, Kelly JP. Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology 2008;115:390-7 e1.
9. Schwartz SR, Blei F, Ceisler E, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J Aapos 2006;10:262-8.
10. Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Ophthalmol 2009;24:178-84.
11. Kushner BJ. The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast Reconstr Surg 1985;76:517-26.
12. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341:173-81.
13. Bennett ML, Fleischer AB Jr, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-13.
14. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51.
15. Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
16. Iaccarino G, Ciccarelli M, Sorriento D, et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-9.
17. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002;38:298-304.
18. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846. author reply 7.
19. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-14.
20. Love JN, Sikka N. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med 2004;26:309-14.
21. Haider KM, Plager DA, Neely DE, et al. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J Aapos 2010;14:251-6.
22. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol 2010;74:323-5.
23. Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-31.
24. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996;132:307-11.
25. Girard C, Bigorre M, Guillot B, et al. PELVIS Syndrome. Arch Dermatol 2006;142:884-8.
26. Buckmiller LM, Munson PD, Dyamenahalli U, et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010;120:676-81.
27. Holmes WJ, Mishra A, Gorst C, et al. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg 2010;125:420-1.
28. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology 2010;117:195-e4.
29. Fay A, Nguyen J, Jakobiec FA, et al. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol 2010;128:256-8.
30. Ranchod TM, Frieden IJ, Fredrick DR. Corticosteroid treatment of periorbital haemangioma of infancy: a review of the evidence. Br J Ophthalmol 2005;89:1134-8.